Tuesday, September 08, 2020 8:34:48 PM
The selling and/or relatively stable price is directly related to what GEM does. IMHFO...
They are the major MM here except for this afternoon's sad news which some people made a decision on. Probably to save a few pennies and NOT having read-up on it. He tested Negative for COVID.
If GEM shuts off the sell???
Formal news is due on several rumors or unconfirmed promises. Wouldn't now be a perfect time to put out OTHER News!!!...GLTA...
My Deepest Respect goes to this Man for his SERVICE and to all his Family for Their Courage. Humanity will study his case and Honor all their Sacrifices for participating in a Clinical Trial.
I was lucky to receive Ipillimamub, Keytruda and Optivo to beat cancers after surgeries and Interferon failed... F#ck Cancer / F#ck COVID...
They are the major MM here except for this afternoon's sad news which some people made a decision on. Probably to save a few pennies and NOT having read-up on it. He tested Negative for COVID.
If GEM shuts off the sell???
Formal news is due on several rumors or unconfirmed promises. Wouldn't now be a perfect time to put out OTHER News!!!...GLTA...
My Deepest Respect goes to this Man for his SERVICE and to all his Family for Their Courage. Humanity will study his case and Honor all their Sacrifices for participating in a Clinical Trial.
I was lucky to receive Ipillimamub, Keytruda and Optivo to beat cancers after surgeries and Interferon failed... F#ck Cancer / F#ck COVID...
Recent RLFTF News
- MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank • ACCESS Newswire • 03/19/2026 06:35:00 AM
- MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics • ACCESS Newswire • 12/23/2025 06:20:00 AM
- Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics • ACCESS Newswire • 12/15/2025 06:20:00 AM
- Relief Therapeutics Shareholders Approve Business Combination with NeuroX • ACCESS Newswire • 11/14/2025 05:40:00 PM
- Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032 • ACCESS Newswire • 10/29/2025 06:20:00 AM
- Micro-Cap Biotech Skyrockets on FDA Pediatric Disease Nod • AllPennyStocks.com • 05/22/2025 04:49:00 PM
